The Precision Peptide Company Inc. (CSE:BPC)
Canada flag Canada · Delayed Price · Currency is CAD
0.3300
-0.0150 (-4.35%)
Apr 2, 2026, 3:52 PM EST

CSE:BPC Income Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
0.090.050.010.290.580.12
Revenue Growth (YoY)
2116.42%307.47%-95.73%-50.84%394.79%-
Cost of Revenue
0.040.030.070.320.540.13
Gross Profit
0.060.02-0.06-0.030.04-0.01
Selling, General & Admin
2.622.160.791.230.820.28
Research & Development
0.060.030.03---
Operating Expenses
3.552.270.961.610.940.28
Operating Income
-3.49-2.25-1.02-1.64-0.9-0.3
Interest & Investment Income
0.010.01----
Currency Exchange Gain (Loss)
0-0.030-0.01-0.01-0
Other Non Operating Income (Expenses)
-----0.19-
EBT Excluding Unusual Items
-3.48-2.28-1.02-1.65-1.09-0.3
Impairment of Goodwill
-0.88-0.88----
Asset Writedown
-1.37-1.37-0.01-0.01-0.04-
Pretax Income
-5.73-4.53-1.03-1.66-1.13-0.3
Net Income
-5.73-4.53-1.03-1.66-1.13-0.3
Net Income to Common
-5.73-4.53-1.03-1.66-1.13-0.3
Shares Outstanding (Basic)
30227651
Shares Outstanding (Diluted)
30227651
Shares Change (YoY)
326.12%224.08%17.56%24.54%589.41%-
EPS (Basic)
-0.19-0.21-0.15-0.29-0.25-0.45
EPS (Diluted)
-0.19-0.21-0.15-0.29-0.25-0.45
Free Cash Flow
-2.73-2.33-0.44-0.98-0.72-0.95
Free Cash Flow Per Share
-0.09-0.11-0.07-0.17-0.16-1.43
Gross Margin
61.96%44.15%--11.48%7.04%-10.69%
Operating Margin
-3764.63%-4529.94%-8354.01%-575.40%-154.78%-252.00%
Profit Margin
-6179.87%-9104.28%-8450.19%-581.35%-194.13%-252.86%
Free Cash Flow Margin
-2944.71%-4694.10%-3601.16%-343.39%-123.69%-808.45%
EBITDA
-3.38-2.16-1.02-1.64-0.9-0.29
EBITDA Margin
-----154.64%-250.67%
D&A For EBITDA
0.110.090000
EBIT
-3.49-2.25-1.02-1.64-0.9-0.3
EBIT Margin
-----154.78%-252.00%
Advertising Expenses
-0.590.040.380.27-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.